AR052161A1 - Derivados de n-[1-(cianometil-carbamoil)-ciclohexil]-4-(4-propil-piperazin-1-il)-benzamida - Google Patents

Derivados de n-[1-(cianometil-carbamoil)-ciclohexil]-4-(4-propil-piperazin-1-il)-benzamida

Info

Publication number
AR052161A1
AR052161A1 ARP050105249A ARP050105249A AR052161A1 AR 052161 A1 AR052161 A1 AR 052161A1 AR P050105249 A ARP050105249 A AR P050105249A AR P050105249 A ARP050105249 A AR P050105249A AR 052161 A1 AR052161 A1 AR 052161A1
Authority
AR
Argentina
Prior art keywords
piperazin
cyanometil
ciclohexil
benzamida
carbamoil
Prior art date
Application number
ARP050105249A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR052161A1 publication Critical patent/AR052161A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones farmacéuticas que los contienen, usos y método de preparacion. Reivindicacion 1: Maleato de hidrogeno de N-[1-(cianometil-carbamoil)-ciclohexil]-4-(4-propil-piperazin-1-il)-benzamida.
ARP050105249A 2004-12-14 2005-12-14 Derivados de n-[1-(cianometil-carbamoil)-ciclohexil]-4-(4-propil-piperazin-1-il)-benzamida AR052161A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427380.1A GB0427380D0 (en) 2004-12-14 2004-12-14 Organic compounds

Publications (1)

Publication Number Publication Date
AR052161A1 true AR052161A1 (es) 2007-03-07

Family

ID=34090027

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105249A AR052161A1 (es) 2004-12-14 2005-12-14 Derivados de n-[1-(cianometil-carbamoil)-ciclohexil]-4-(4-propil-piperazin-1-il)-benzamida

Country Status (6)

Country Link
AR (1) AR052161A1 (es)
GB (1) GB0427380D0 (es)
GT (1) GT200500365A (es)
PE (1) PE20060742A1 (es)
TW (1) TW200635910A (es)
WO (1) WO2006063762A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2678717A1 (en) * 2007-02-28 2008-09-04 Sanofi-Aventis Imaging probes
EP2262783A2 (en) * 2008-02-21 2010-12-22 Sanofi-Aventis Covalently binding imaging probes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1273444C (zh) * 1997-11-05 2006-09-06 诺瓦提斯公司 二肽腈
GB0003111D0 (en) * 2000-02-10 2000-03-29 Novartis Ag Organic compounds
PE20050328A1 (es) * 2003-07-21 2005-06-16 Novartis Ag Combinaciones de un bisfosfonato y un inhibidor de catepsina k
JP2007511548A (ja) * 2003-11-19 2007-05-10 ノバルティス アクチエンゲゼルシャフト 重篤な骨量減少疾患におけるカテプシンｋ阻害剤の使用

Also Published As

Publication number Publication date
GB0427380D0 (en) 2005-01-19
GT200500365A (es) 2006-07-17
WO2006063762A1 (en) 2006-06-22
TW200635910A (en) 2006-10-16
PE20060742A1 (es) 2006-09-08

Similar Documents

Publication Publication Date Title
MEP53708A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl) -n-methyl -amino) -anilino)-1- phenyl-methylene] -6-methoxycarbonyl -2-indolinone -monoethanesulphonate and the use thereof as a pharmaceutical composition
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
NO20014485D0 (no) Nye forbindelser og sammensetninger som proteaseinhibitorer
DE60305724D1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
NO20072005L (no) Nye heterocykliske amider
UY28348A1 (es) Compuestos novedosos
AR056337A1 (es) Derivados de alquil-, alquenil- y alquinilcarbamatos, su preparacion y su aplicacion en terapeutica
DE50009736D1 (de) Biphenylderivate, ihre herstellung und ihre verwendung als mtp-inhibitor
UY27870A1 (es) Nuevos derivados de quinuclidina-amida
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
BRPI0415710A (pt) formas polimórficas de n-[(r)-2,3-dihidróxi-propóxi]-3,4-diflúor-2-(2-flúor-4-io dofenilamino)-benzamida
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
NO20023932D0 (no) Nye forbindelser
ATE343366T1 (de) Kapseln zum einbau in waschmittel- oder körperpflegezusammensetzungen
NO20045065L (no) Nytt formatsalt av o-desmetyl-venlafaxin
EA200501268A1 (ru) Ингибирующие вич 1,2,4-триазины
EA200700367A1 (ru) Новые производные 4-бензилиденпиперидина
NO20054787D0 (no) Indenderivater som farmasotiske midler
NO20052520L (no) Nye sulfamider
ES2163735T3 (es) Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
EA200400708A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
NO20055368L (no) Kombinasjoner av paroksetin og 4-(S)-(4-acetyl-piperazin-1-yl-)-2-(R)-(4-trifluor-2-metyl-fenyl)-piperidin-1-karboksylsyre{1\\[1-(R)-3,5-bis-trifluormetyl-fenyl)-etyl]metylamid for behandling av depresjon og/eller angst
NO973857D0 (no) 1-aryl-2-acylamino-etanforbindelser og deres anvnedelse som neurokinin-, spesielt neurokinin-1-antagonister
AR052161A1 (es) Derivados de n-[1-(cianometil-carbamoil)-ciclohexil]-4-(4-propil-piperazin-1-il)-benzamida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal